Clinical Trials Logo

Clinical Trial Summary

To analyze the short-term outcomes of posterior corpectomy of patients with thoracolumbar spinal metastasis in spine unit in Assiut University hospital regarding the pain control , neurological status , complication and ambulatory status as well as mortality rate.


Clinical Trial Description

The metastasis is the spread of cancer from one part of the body to another. Two-thirds of patients with cancer will develop bone metastases. Breast, prostate and lung cancer are responsible for more than 80% of cases of metastatic bone disease. A spinal metastasis may cause pain, instability and neurological injuries. - The spine is the most common site of bone metastasis . It is estimated that over the 10% of patients with cancer will develop a symptomatic spinal metastasis . Algra et al. suggest that the initial anatomic location of metastases within vertebrae is in the posterior portion of the body. - Spinal metastases are the most common tumors of the spine, comprising approximately 90% of masses encountered with spinal imaging. Within the spinal column, metastasis is more commonly found in the thoracic region, followed by the lumbar region, while the cervical region is the least likely place professionals find metastasis . - Spinal metastases most commonly affect the vertebral bodies of the spinal column, and spinal cord compression is an indication for surgery. Commonly, an open posterior approach is employed to perform a transpedicular, costotransversectomy or lateral extracavitary corpectomy. Because of the short life expectancies in patients with metastatic spinal disease, decreasing the morbidity of surgical treatment and recovery time is critical. - At present, both surgical and nonsurgical treatments are used for the treatment of spinal tumors, however, treatment outcome is dependent on various factors, such as patient age, overall health of the patient . - When treating patients with vertebral metastases, surgical strategy is mainly based on life expectancy, primary site of tumor, and staging. This helps determine which patients will benefit from surgery and the type of procedure. Tokuhashi developed a score to determine life expectancy in order to facilitate the treatment modality decision . - Vertebral corpectomy refers to the removal of one or more vertebral bodies from the spine, as well as the intervertebral discs above and below the surgical level. Corpectomies may be accomplished through a multitude of approaches. Posterior approaches have been associated with less intraop- erative blood loss, complications, shorter operative time, and better pul- monary function post-operation compared to anterior approaches . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06117475
Study type Observational
Source Assiut University
Contact Rehab Ma Ahmed, Resident
Phone 01025345048
Email rehabmahmoud@med.aun.edu.eg
Status Not yet recruiting
Phase
Start date November 1, 2023
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05023772 - Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases N/A
Suspended NCT04115254 - Stereotactic Magnetic Resonance Guided Radiation Therapy N/A
Recruiting NCT04375891 - Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation N/A
Recruiting NCT04802603 - Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column N/A
Not yet recruiting NCT04635137 - Ablation and Cementoplasty for Painful Bone Lesions N/A
Recruiting NCT03963713 - Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors N/A
Active, not recruiting NCT04227717 - Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine
Recruiting NCT04218617 - Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases Phase 2
Completed NCT02367378 - Minimally Invasive Surgery (MIS) for Spine Metastases N/A
Recruiting NCT06165419 - Definitive Radiation for High-Risk Spine Metastases Phase 2
Recruiting NCT05534321 - Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease Phase 1/Phase 2
Recruiting NCT05495399 - Post Operative RT for Limited Spine Metastases N/A
Recruiting NCT05317026 - Increased Early Pain Relief by Adding Vertebroplasty to SBRT N/A
Terminated NCT02174107 - Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases. N/A